Advertisement
News
Advertisement

MDRNA buys technology from Valeant

Wed, 03/24/2010 - 4:17am
The Associated Press

Biotechnology company MDRNA Inc. said Tuesday it bought DNA technology-related patents from Valeant Pharmaceuticals for an undisclosed amount.

The patents give MDRNA considerable breadth in the research and development of nucleic acid-based therapies, MDRNA said, in a statement.

MDRNA is developing drugs that fight cancer and other diseases with "gene-silencing" RNA interference technology.

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading